Advertisement
| epoprostenol therapy side effects: Hepatotoxicity Hyman J. Zimmerman, 1999 Written by the foremost authority in the field, this volume is a comprehensive review of the multifaceted phenomenon of hepatotoxicity. Dr. Zimmerman examines the interface between chemicals and the liver; the latest research in experimental hepatotoxicology; the hepatotoxic risks of household, industrial, and environmental chemicals; and the adverse effects of drugs on the liver. This thoroughly revised, updated Second Edition features a greatly expanded section on the wide variety of drugs that can cause liver injury. For quick reference, an appendix lists these medications and their associated hepatic injuries. Also included are in-depth discussions of drug metabolism and factors affecting susceptibility to liver injury. |
| epoprostenol therapy side effects: Primary Pulmonary Hypertension Lewis J. Rubin, Stuart Rich, 1996-11-06 Detailing state-of-the-art developments in the various aspects of primary pulmonary hypertension (PPH), this practical reference explores the history, most current scientific concepts, and treatments of this disease. Includes new advances not yet formally published! Written by nearly 30 of the top international experts in the field, Primary Pulmonary Hypertension addresses the general histological features of the normal and hypertensive pulmonary vasculature and the pathology of PPH discusses etiological possibilities of pathogenesis, common morphological features, and findings in experimental models examines risks factors for PPH and looks separately at familial PPH and PPH in children presents an approach to the differential diagnosis of pulmonary hypertension, emphasizing the recognition of PPH elucidates the invasive and noninvasive modalities available for obtaining qualitative and quantitative hemodynamic data for the diagnosis of PPH covers a variety of therapeutic options and much more! |
| epoprostenol therapy side effects: Introduction to Basics of Pharmacology and Toxicology Abialbon Paul, Nishanthi Anandabaskar, Jayanthi Mathaiyan, Gerard Marshall Raj, 2021-03-13 This book explains the pharmacological relationships between the various systems in the human body. It offers a comprehensive overview of the pharmacology concerning the autonomic, central, and peripheral nervous systems. Presenting up-to-date information on chemical mediators and their significance, it highlights the therapeutic aspects of several diseases affecting the cardiovascular, renal, respiratory, gastrointestinal, endocrinal, and hematopoietic systems. The book also includes drug therapy for microbial and neoplastic diseases. It also comprises sections on immunopharmacology, dermatological, and ocular pharmacology providing valuable insights into these emerging and recent topics. Covering the diverse groups of drugs acting on different systems, the book reviews their actions, clinical uses, adverse effects, interactions, and subcellular mechanisms of action. It is divided into 11 parts, subdivided into several chapters that evaluate the basic pharmacological principles that govern the different types of body systems. This book is intended for academicians, researchers, and clinicians in industry and academic institutions in pharmaceutical, pharmacological sciences, pharmacy, medical sciences, physiology, neurosciences, biochemistry, molecular biology and other allied health sciences. |
| epoprostenol therapy side effects: Cardiovascular Disability Institute of Medicine, Board on the Health of Select Populations, Committee on Social Security Cardiovascular Disability Criteria, 2010-12-04 The Social Security Administration (SSA) uses a screening tool called the Listing of Impairments to identify claimants who are so severely impaired that they cannot work at all and thus immediately qualify for benefits. In this report, the IOM makes several recommendations for improving SSA's capacity to determine disability benefits more quickly and efficiently using the Listings. |
| epoprostenol therapy side effects: Meyler's Side Effects of Drugs Jeffrey K. Aronson, 2015-10-15 Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions, Sixteenth Edition, Seven Volume Set builds on the success of the 15 previous editions, providing an extensively reorganized and expanded resource that now comprises more than 1,500 individual drug articles with the most complete coverage of adverse reactions and interactions found anywhere. Each article contains detailed and authoritative information about the adverse effects of each drug, with comprehensive references to the primary literature, making this a must–have reference work for any academic or medical library, pharmacologist, regulatory organization, hospital dispensary, or pharmaceutical company. The online version of the book provides an unparalleled depth of coverage and functionality by offering convenient desktop access and enhanced features such as increased searchability, extensive internal cross-linking, and fully downloadable and printable full-text, HTML or PDF articles. Enhanced encyclopedic format with drug monographs now organized alphabetically Completely expanded coverage of each drug, with more than 1,500 drug articles and information on adverse reactions and interactions Clearer, systematic organization of information for easier reading, including case histories to provide perspective on each listing Extensive bibliography with over 40,000 references A must–have reference work for any academic or medical library, pharmacologist, regulatory organization, hospital dispensary, or pharmaceutical company |
| epoprostenol therapy side effects: Cardiothoracic Critical Care E-Book David Sidebotham, Andrew McKee, Michael Gillham, Jerrold Levy, 2007-09-12 This new bedside manual guides you through all the practical aspects of managing patients following cardiothoracic surgery and critically ill cardiology patients. Primarily designed to use in cardiothoracic intensive care units and coronary care units, it covers the perioperative management for the full range of cardiothoracic surgical procedures, the management of complications, and related issues. Core topics in cardiothoracic critical care, such as hemodynamic instability, arrhythmias, bleeding, and mechanical cardiac support, are afforded broad coverage. Also included are sections on advanced ventilatory techniques and veno-venous ECMO for treating severe respiratory failure, as well as nutritional support, treating and preventing infection, renal failure, and care of the dying patient. Concisely written and featuring liberal use of illustrations as well as an integrated, tightly edited style, and a limited number of key references, this volume will become your reference of choice for the care of of cardiothoracic surgery patients and critically ill cardiology patients. Find information quickly with concisely written text. Get a more complete picture with extensive illustrations. Focus on just the information you need using a a limited number of key references. Navigate the complexities of critical care for a fulll range of cardiothoracic surgery patients with in-depth coverage of perioperative care, management of complications, and more. |
| epoprostenol therapy side effects: Continuous Renal Replacement Therapy John A. Kellum, Rinaldo Bellomo, Claudio Ronco, 2016 Continuous Renal Replacement Therapy provides concise, evidence-based, bedside guidance for the management of critically ill patients with acute renal failure, offering quick reference answers to clinicians' questions about treatments and situations encountered in daily practice. |
| epoprostenol therapy side effects: Meyler's Side Effects of Drugs 15E Jeffrey K. Aronson, 2014-04-11 Building on the success of the 14 previous editions, this remarkable reference has been extensively reorganized and expanded and now comprises almost 1,500 individual drug articles providing the most complete coverage of adverse reactions and interactions found anywhere. Each article contains detailed and authoritative information about the adverse effects of each drug, with comprehensive references to the primary literature making this a must have for any academic or medical library, pharmacologist, regulatory organization, hospital dispensary or pharmaceutical company. Now available online for all academic, corporate or government institution as well as individuals viaScience Direct! The online version provides an unparalleled depth of coverage and functionality by offering convenient desktop access and enhanced features such as increased searchability, extensive internal cross-linking and fully downloadable and printable full-text, HTML or PDF articles. Enhanced encyclopedic format with drug monographs now organised alphabetically Completely expanded coverage of each drug - thalidomide warranted three sentences in Meyler's 14th edition, but is now a 13 page extensive monograph Clearer, systematic organization of information for easier reading including case histories to provide perspective on each listing Extensive bibliography with over 40,000 references - Meyler's 15th edition incorporates all relevant citations from Meyler's 14th, but also includes relevant citations from previous editions of Meyler's and Side Effects of Drugs Annuals to give a historical perspective on the use and safety of drugs |
| epoprostenol therapy side effects: Meyler's Side Effects of Endocrine and Metabolic Drugs Jeffrey K. Aronson, 2009-02-21 Elsevier now offers a series of derivative works based on the acclaimed Meylers Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing physician or health care clinician. Endocrine and metabolic diseases are common, includes diseases such as diabetes, thyroid disease, and obesity. Endocrinologists, including diabetes professionals, internal medicine and primary care practitioners, obstetricians and gynecologists, and others will find this book useful when treating endocrine or metabolic diseases.The material is drawn from the 15th edition of the internationally renowned encyclopedia, Meyler's Side Effects of Drugs, and the latest volumes in the companion series, Side Effects of Drugs Annuals. Drug names have usually been designated by their recommended or proposed International Non-proprietary Names (rINN or pINN); when those are not available, clinical names have been used. In some cases, brand names have been used.This volume is critical for any health professional involved in the administration of endocrine and metabolics mediations. - - Surpasses the Physician's Desk Reference © by including clinical case studies and independent expert analysis - Complete index of drug names - Most complete cross referencing of drug-drug interactions available - Extensive references to primary and secondary literature - Also includes information on adverse effects in pregnancy The book is divided into eight sections: - Corticosteroids and related drugs - Prostaglandins - Sex hormones and related drugs - Iodine and drugs that affect thyroid function - Insulin and other hypoglycemic drugs - Other hormones and related drugs - Lipid-regulated drugs - Endocrine and metabolic adverse effects of non-hormonal and non-metabolic drugs |
| epoprostenol therapy side effects: Diagnosis and Treatment of Pulmonary Hypertension Yoshihiro Fukumoto, 2017-01-05 This book focuses on pulmonary arterial hypertension (PAH, Group 1) and chronic thromboembolic pulmonary hypertension (CTEPH, Group 4) among the various groups of pulmonary hypertension (PH) whose classification was updated into five major categories at the 5th World Symposium held in Nice, France, in 2013. Readers will find recent progress, methods, and up-to-date information on PH mechanisms, diagnostic images, and treatment in the management of PH.This volume, with contributions by leading researchers worldwide in the field , consists of five parts, starting with the fundamentals of PH, then pathophysiology and genetics, treatment, and right ventricular function. |
| epoprostenol therapy side effects: Practical Handbook of Thoracic Anesthesia Philip M. Hartigan, 2012-01-07 This comprehensive handbook delivers “bottom line,” evidence-based guidance in the practice of thoracic anesthesia. Chapters are short and practical and include actionable technical pearls not available elsewhere. The editor and contributors are academic faculty who work at one of the busiest thoracic surgical programs in North America, and their aim has been to integrate essential concepts with practical decision-making. •Detailed guidance for performing more than 30 thoracic surgical procedures •Relevant surgical insights from a senior thoracic surgeon included for each procedure •Full range of modern thoracic anesthetic challenges covered •Essential foundation concepts digested and simplified •Technical aspects sufficiently detailed to be useful •An efficient resource for skilled generalists and trainees |
| epoprostenol therapy side effects: Side Effects of Drugs Annual , 2015-11-26 Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions was first published in 1977, and has been continually published as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs. Each Annual provides clinicians and medical investigators with a reliable and critical survey of new data and trends in the area of adverse drug reactions and interactions, with an international team of specialists contributing their expertise each year. - Provides a critical yearly survey of the new data and trends regarding the side effects of drugs - Authored and reviewed by pioneers throughout the world in the clinical and practice sciences - Presents an essential clinical on the side effects of drugs for practitioners and healthcare professionals |
| epoprostenol therapy side effects: Pulmonary Vascular Disorders Marc Humbert, R. Souza, Gérald Simonneau, 2012 An excellent overview of recent advances in diagnosis, classification and treatment The pulmonary circulation is by nature difficult to evaluate for the clinician and a challenge to investigate by radiographic and hemodynamic methods. In recent years, the field has been revolutionized by major improvements in diagnostic approaches and therapies. Tools for the classification, diagnosis, and management of pulmonary embolism and pulmonary hypertension have been developed and optimized, providing clinicians with detailed and updated guidelines. This volume provides the latest information on the fast-growing and challenging field of acute and chronic pulmonary vascular disorders from some of the field's major leaders in research, education, and care. The topics discussed are relevant to chest physicians, thoracic surgeons, nurses, students, and teachers, and a well-balanced mix of contributions ensures that doctors, clinicians, and institutions from all around the world will find the information presented to be both informative and useful to their situations. |
| epoprostenol therapy side effects: Molecular Mechanism of Congenital Heart Disease and Pulmonary Hypertension Toshio Nakanishi, H. Scott Baldwin, Jeffrey R. Fineman, Hiroyuki Yamagishi, 2020-02-28 This open access book focuses on the molecular mechanism of congenital heart disease and pulmonary hypertension, offering new insights into the development of pulmonary circulation and the ductus arteriosus. It describes in detail the molecular mechanisms involved in the development and morphogenesis of the heart, lungs and ductus arteriosus, covering a range of topics such as gene functions, growth factors, transcription factors and cellular interactions, as well as stem cell engineering technologies. The book also presents recent advances in our understanding of the molecular mechanism of lung development, pulmonary hypertension and molecular regulation of the ductus arteriosus. As such, it is an ideal resource for physicians, scientists and investigators interested in the latest findings on the origins of congenital heart disease and potential future therapies involving pulmonary circulation/hypertension and the ductus arteriosus. |
| epoprostenol therapy side effects: Meyler's Side Effects of Drugs in Cancer and Immunology Jeffrey K. Aronson, 2010-04-19 Elsevier now offers a series of derivative works based on the acclaimed Meyler's Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing biomedical researcher and/or clinician. There has been significant progress in the development of targeted therapy drugs that act specifically on certain cancers, and that minimize damage to normal cells. Oncologists and cancer researchers will rely on this volume to determine effective drug treatments. - The only drug guide that includes clinical case studies and expert analysis - UNIQUE! Features not only anticancer drugs, but also all other drugs that act upon related organ systems affected by cancer - Most complete cross referencing of drug-drug interactions available - Latest content from the most highly regarded compilation of drug side effects: Side Effects of Drugs Annual serial |
| epoprostenol therapy side effects: Pulmonary Hypertension Bradley A. Maron, Roham T. Zamanian, Aaron B. Waxman, 2015-11-02 This book provides the framework for a singular reference in the field of pulmonary hypertension. Pulmonary vascular disease is a complex and heterogeneous condition characterized by remodeling of distal pulmonary arterioles that increases pulmonary vascular resistance to affect cardiopulmonary hemodynamic and right ventricular function adversely, resulting in a clinical syndrome of diminished exercise tolerance, shortness of breath, and heart failure-associated morbidity and mortality. Owing to the availability of novel pulmonary circulation-selective pharmacotherapies over the previous decade, the number of pulmonary hypertension patients eligible for treatment has increased substantially. Despite this progress, under-awareness persists within the practicing pulmonary, cardiovascular, and general internal medicine communities. This is due, in part, to the complex array of molecular mechanisms implicated in the pathobiology of PH, as well as cutting-edge discoveries from translational scientific works that provide a new framework by which to understand pulmonary vascular-right ventricular coupling. Taken together, a key educational opportunity is exposed to bridge this knowledge gap through the synthesis of a contemporary text that emphasizes basic science, translational and clinical principles, and treatment strategies for understanding pulmonary hypertension. |
| epoprostenol therapy side effects: Handbook of Critical and Intensive Care Medicine Joseph Varon, Pilar Acosta, 2010-03-20 Why write a book on the management of critically ill patients? Over the past few decades we have seen an enormous growth in the number of intensive care units (ICU) across the world. Indeed, it is estimated that a large proportion of health care expenses are devoted to patients in these specialized units. Medical students, r- idents, fellows, attending physicians, critical care nurses, pharmacists, respiratory therapists, and other health-care providers (irrespective of their ultimate ?eld of pr- tice) will spend several months or years of their professional lives taking care of critically ill or severely injured patients. These clinicians must have special tra- ing, experience, and competence in managing complex problems in their patients. Moreover, these clinicians must interpret data obtained by many kinds of monitoring devices, and they must integrate this information with their knowledge of the pat- physiology of disease. Even more important is the fact that anyone working in an ICU or with a critically ill patient must approach patients with a multidisciplinary team. The phrase there is no I in TEAM comes to mind. |
| epoprostenol therapy side effects: Anesthetic Pharmacology Alex S. Evers, Mervyn Maze, Evan D. Kharasch, 2011-03-10 In recent years our understanding of molecular mechanisms of drug action and interindividual variability in drug response has grown enormously. Meanwhile, the practice of anesthesiology has expanded to the preoperative environment and numerous locations outside the OR. Anesthetic Pharmacology: Basic Principles and Clinical Practice, 2nd edition, is an outstanding therapeutic resource in anesthesia and critical care: Section 1 introduces the principles of drug action, Section 2 presents the molecular, cellular and integrated physiology of the target organ/functional system and Section 3 reviews the pharmacology and toxicology of anesthetic drugs. The new Section 4, Therapeutics of Clinical Practice, provides integrated and comparative pharmacology and the practical application of drugs in daily clinical practice. Edited by three highly acclaimed academic anesthetic pharmacologists, with contributions from an international team of experts, and illustrated in full colour, this is a sophisticated, user-friendly resource for all practitioners providing care in the perioperative period. |
| epoprostenol therapy side effects: Acute Pulmonary Embolism A. Geibel, Hanjoerg Just, W. Kasper, S. Konstantinides, 2012-12-06 The value of echocardiography in the diagnostic work-up of patients with suspected acute pulmonary embolism.- New developments in the thrombolytic therapy of venous thrombosis.- Mechanism of blood coagulation. Newer aspects of anticoagulant and antithrombotic therapy.MR-angiography in the diagnosis of pulmonary embolism.Scintigraphy-ventilation/perfusion scanning and imaging of the embolus.- Clinical course and prognosis of acute pulmonary embolism.- The molecular mechanisms of inherited thombophilia. |
| epoprostenol therapy side effects: Synopsis of Neurology, Psychiatry and Related Systemic Disorders Alan B. Ettinger, Deborah M. Weisbrot, Casey E. Gallimore, 2019-05-31 Symptoms and signs in neurology and psychiatry typically present in the clinical context of other underlying conditions. When evaluating a patient, a physician may choose to review a diverse list of potential underlying diagnoses with the aid of the editor team's existing text: Neurological Differential Diagnosis: A Case-Based Approach. However, if the patient has a known pre-existing condition, the physician will need to consider a reverse approach - considering what complications of that condition may be associated with current symptoms. This book provides quick-reference, comprehensive, concise summaries of neurologic, psychiatric and medical diagnoses with a focus on neurologic and psychiatric implications of systemic disorders. A separate pharmacology section provides a consolidated review of potential neurologic and psychiatric adverse effects of medications. This book is an invaluable resource for a broad medical audience, from the medical student to the experienced consultant. |
| epoprostenol therapy side effects: Core Topics in Cardiothoracic Critical Care Kamen Valchanov, Nicola Jones, Charles W. Hogue, 2018-07-05 Most patients with critical cardiac or thoracic conditions will at some stage pass through the cardiothoracic critical care unit. Critical care presents more complex clinical data than any other area of medicine. The new edition of Core Topics in Cardiothoracic Critical Care focuses on the latest practise in the management of patients in cardiothoracic intensive care. The practice of cardiothoracic critical care medicine is constantly evolving, and this new edition reflects the modernized learning styles for trainees. Each chapter includes key learning points as well as sample multiple choice questions and answers to assist in exam preparation. This edition also features updated chapters on ECMO, perioperative management of patients undergoing emergency cardiothoracic surgery, and advanced modes of organ support for patients. This text provides key knowledge in a concise and accessible manner for trainees, clinicians and consultants from specialities and disciplines such as cardiology and anaesthesia, and nursing and physiotherapy. |
| epoprostenol therapy side effects: Mayo Clinic Cardiology Concise Textbook and Mayo Clinic Cardiology Board Review Questions & Answers Joseph G. Murphy, Margaret A. Lloyd, 2007-12-14 Master the cardiology boards and save money, with our new convenient Mayo Clinic Cardiology: Course Pack. Packed with hundreds of board-focused questions, this new course pack saves over $19.00 and includes the complete Mayo Clinic Cardiology: Concise Textbook, Third Edition PLUS the Mayo Clinic Cardiology: Board Review Questions and Answers. Focus |
| epoprostenol therapy side effects: Side Effects of Drugs Annual Jeffrey K Aronson, 2011-11-18 The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then as a yearly update to the voluminous encyclopedia, Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of adverse drug reactions and interactions. An international team of specialists has contributed to the informative Annual by critically interpreting it and by pointing to whatever is misleading. - Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of adverse drug reactions and interactions - An international team of specialists has contributed to the informative Annual by critically interpreting it and by pointing to whatever is misleading |
| epoprostenol therapy side effects: Pulmonary Circulation Andrew J. Peacock, Robert Naeije, Lewis J. Rubin, 2016-03-23 Pulmonary Circulation provides physicians with a better understanding of the structure, function and pathophysiology of the pulmonary circulation. It provides comprehensive coverage from diagnosis and clinical evaluation of patients with pulmonary hypertension to imaging techniques, disorders and treatment. This new edition incorporates the latest clinical, pathophysiological and pathological research on pulmonary circulatory disorders. In particular, it provides greater emphasis on the role of the right ventricle in pulmonary vascular disease, updated knowledge on pathobiology and genetics, and includes new material related to imaging and other diagnostic modalities. This edition also reflects new classifications and all the recommendations from the 2013 World Conference on Pulmonary Circulation as well as current guidelines from the European Society of Cardiology and the European Respiratory Society. Thoroughly updated to keep up with the brisk pace of discovery and emerging therapies, the book remains an essential resource by providing a balance between scientific review and clinically relevant guidelines for the busy practicing physician. |
| epoprostenol therapy side effects: Side Effects of Drugs Annual Sidhartha D. Ray, 2021-11-04 Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions, Volume 43, first published in 1977, and continually published as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs, presents clinicians and medical investigators with a critical survey of new data and trends in adverse drug reactions and interactions. Topics covered in this new release include Central Nervous System Stimulants and Drugs that Suppress Appetite, Antidepressants, Lithium, Drugs of Abuse, Hypnotics and Sedatives, Antipsychotic Drugs, Antiepileptics, Opioid Analgesics and Narcotic Antagonists, Anti-Inflammatory and Antipyretic Analgesics and Drugs Used in Gout, and much more. - Provides a critical yearly survey of the new data and trends regarding the side effects of drugs - Authored and reviewed by worldwide pioneers in the clinical and practice sciences - Presents an essential clinical guide on the side effects of drugs for practitioners and healthcare professionals alike |
| epoprostenol therapy side effects: Pulmonary Vascular Disease Jess Mandel, Darren Taichman, 2006 Offers a current and comprehensive review of the pathophysiology, diagnosis, and treatment of pulmonary hypertension and venous thromboembolism. Discusses indepth the pharmacologic and non-pharmacologic therapies used in the treatment of pulmonary vascular disease -- including the benefits and risks of each -- allowing for more informed care decisions. |
| epoprostenol therapy side effects: Elsevier's 2022 Intravenous Medications - E-Book Shelly Rainforth Collins, 2021-04-16 Find the essential information you need to safely administer more than 400 intravenous drugs! For more than 45 years, Gahart’s Intravenous Medications: A Handbook for Nurses and Health Professionals has been a trusted resource for comprehensive drug coverage, unparalleled accuracy, and an intuitive quick-access format. In addition to updated drug interactions, precautions, alerts, and patient teaching instructions for all existing IV drugs, the 2022 edition includes approximately 10 new monographs of the most recent IV drugs to be approved by the FDA. Administering intravenous drugs is a critical task — inaccurate or out-of-date information is not an option. Known as the #1 IV drug handbook on the market, and with its history of impeccable accuracy, Gahart’s annual publication gives you the extra confidence and guidance you need to safely and effectively treat patients. Monographs on more than 400 IV drugs offer an impressive breadth of coverage that goes well beyond any comparable drug reference. Updated annual publication prevents you from referencing outdated information. Additional drug monographs are provided on the companion Evolve website. 45-year history of impeccable accuracy reinforces the importance of safe IV drug administration. Perfect depth of information equips you with everything that is needed for safe administration of IV drugs — nothing more, nothing less. Proven, clinically optimized format keeps all dosage information for each drug on either a single page or a two-page spread to prevent hand contamination by having to turn a page. Highlighted Black Box Warnings and relevant content make locating critical information fast and easy. Special circumstances in blue-screened text call attention to important circumstances that may not warrant Black Box Warnings. Life-stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients. Dilution and dosage charts within monographs provide quick access to essential clinical information. Convenient, alphabetical format organizes all drug monographs by generic name, allowing you to find any drug in seconds. NEW! Drug monographs for newly approved drugs by the FDA provide you with the most current drug information. Updates on drug interactions, precautions, alerts, and more have been made throughout the guide to reflect all changes to existing medications. |
| epoprostenol therapy side effects: Practical Cardiology Ragavendra R. Baliga, Kim A. Eagle, 2013-08-08 Thoroughly updated to reflect current American College of Cardiology/American Heart Association guidelines, this concise yet comprehensive handbook presents practical information on the common cardiovascular problems that clinicians encounter daily. The book provides a user-friendly, authoritative guide to evaluation of common cardiovascular symptoms and evaluation and management of common cardiovascular conditions. Coverage also includes clinical challenges such as management of chronic anticoagulation, assessing and minimizing cardiac risk in noncardiac surgery, and management of the cardiac surgery patient. Numerous tables and algorithms help readers find information quickly and aid in clinical decision-making. |
| epoprostenol therapy side effects: Pediatric Pharmacotherapy Sandra Benavides, 2012 |
| epoprostenol therapy side effects: The Diagnosis of Psychosis Rudolf N. Cardinal, Edward T. Bullmore, 2011-03-31 Psychosis has many causes. Psychiatrists typically receive the most thorough training in its diagnosis, but the diagnosis of psychosis secondary to nonpsychiatric conditions is not often emphasized. An understanding of the underlying cause of psychosis is important for effective management. The Diagnosis of Psychosis bridges the gap between psychiatry and medicine, providing a comprehensive review of primary and secondary causes of psychosis. It covers both common and rare causes in a clinically focused guide. Useful both for teaching and reference, the text covers physical and mental state examination, describes key investigations, and summarizes the non-psychiatric features of medical conditions causing psychosis. Particularly relevant for psychiatrists and trainees in psychiatry, this volume will also assist neurologists and general physicians who encounter psychosis in their practice. |
| epoprostenol therapy side effects: Maternal Hemodynamics Christoph Lees, Wilfried Gyselaers, 2018-05-03 Discover new concepts in cardiovascular and hemodynamic functionality in feto-maternal medicine, from leading experts in the field. |
| epoprostenol therapy side effects: Iloprost in Intensive Care Medicine Ralf Ewert, 2009 |
| epoprostenol therapy side effects: Diagnosis and Management of Pulmonary Hypertension James R. Klinger, Robert P. Frantz, 2015-05-25 This book provides an overview of pulmonary hypertensive diseases, the current understanding of their pathobiology, and a contemporary approach to diagnosis and treatment. It discusses the definition and classification of these disorders and the epidemiology of pulmonary arterial hypertension (PAH); explores the approach to diagnosis and evaluation via methods such as echocardiography, right heart catheterization, and cardiopulmonary exercise testing; describes the major drug classes used to treat PAH and the cell signaling pathways that they target as well as adjunct and investigative therapies; and highlights special situations that are particularly challenging in the management of PAH. Written by experts in their respective fields, Diagnosis and Management of Pulmonary Hypertension is a valuable resource for pulmonologists, cardiologists, and practitioners in internal medicine and critical care. |
| epoprostenol therapy side effects: Perioperative Critical Care Cardiology J.L. Atlee, A. Gullo, G. Sinagra, J.L. Vincent, 2007-03-14 This book details topics of particular importance to critical care cardiovascular diagnosis and management in the perioperative period. It represents an important update for anaesthesiologists, cardiologists, cardiac surgeons, emergency care physicians and intensivists caring for patients with acute, life-threatening cardiovascular afflictions |
| epoprostenol therapy side effects: Clinical Respiratory Medicine Richard K. Albert, Stephen G. Spiro, James R. Jett, 2008-04-16 This comprehensive clinical textbook examines all aspects of respiratory medicine. The editors take a practical approach to the diagnosis and management of patients with the full range of pulmonary disorders, making this your ideal source for reference in clinical practice. Fully revised, this essential volume includes new chapters on PET imaging, implications of genetic research, oxygen therapy, and rehabilitation. Now an Expert Consult title, it comes with access to the complete contents of the book online, including all of the book’s images, downloadable for use in presentations. Provides complete clinical coverage so you can Better manage and treat patients with pulmonary disease. Uses templated, clinical chapters for consistent, concise, essential information. Includes coverage that reflects the way you practice medicine today with critical information relevant to everyday practice. Utilizes diagnostic algorithms to help you find critical information and at a glance. Includes new chapters on PET imaging, implications of genetic research, oxygen therapy, and rehabilitation to keep you up to date. Includes access to the complete contents of the book online, including all of the book’s images, downloadable for use in presentations. |
| epoprostenol therapy side effects: Liver Pathophysiology Pablo Muriel, 2017-03-02 Liver Pathophysiology: Therapies and Antioxidants is a complete volume on morphology, physiology, biochemistry, molecular biology and treatment of liver diseases. It uses an integral approach towards the role of free radicals in the pathogenesis of hepatic injury, and how their deleterious effects may be abrogated by the use of antioxidants. Written by the most prominent authors in the field, this book will be of use to basic and clinical scientists and clinicians working in the biological sciences, especially those dedicated to the study and treatment of liver pathologies. - Presents the most recent advances in hepatology, with a special focus on the role of oxidative stress in liver injury. - Provides in vivo and in vitro models to study human liver pathology. - Explains the beneficial effects of antioxidants on liver diseases. - Contains the most recent and modern treatments of hepatic pathologies, including, but not limited to, stem cells repopulation, gene therapy and liver transplantation. |
| epoprostenol therapy side effects: Pulmonary Arterial Hypertension, An Issue of Clinics in Chest Medicine Terence K. Trow, 2013-12-28 Guest editor Terence K. Trow has assembled an expert team of authors on the topic of Pulmonary Arterial Hypertension. Articles include: Epidemiology of Pulmonary Arterial Hypertension, Pathology of Pulmonary Hypertension, Genetics of Pulmonary Arterial Hypertension, Diagnosis of Pulmonary Arterial Hypertension, Pulmonary Hypertension Owing to Left Heart Disease, Pulmonary Hypertension due to Lung Disease and/or Hypoxia, Pulmonary Arterial Hypertension Associated with Congenital Heart Disease, World Health Organization Group 5 Pulmonary Hypertension, and more! |
| epoprostenol therapy side effects: Pulmonary Arterial Hypertension Robyn Barst, 2008-09-15 First book dedicated to this disease, previously thought to be incurable, but with the advent of new drugs, now amenable to management and a much improved prognosis for patients From the PAH Association, the leading experts in field Incorporates the latest AACP management guidelines Includes evidence-based treatment algorithms based on the recently updated ACCP Guidelines for Medical Treatment Aimed at specialists in pulmonology and cardiovascular disease, this volume provides the clinician with the most up to date information on the effective management of PAH |
| epoprostenol therapy side effects: Pediatric Critical Care E-Book Jerry J. Zimmerman, 2016-11-29 Still the #1 resource for today’s pediatric ICU teams, Pediatric Critical Care, 5th Edition covers the entire field, from basic science to cutting-edge clinical applications. Drs. Bradley P. Fuhrman and Jerry J. Zimmerman, accompanied by an expert team of editors and contributors from around the world, bring you today’s best information on the current and future landscape of pediatric critical care so you can consistently deliver optimum care to your young patients. Boasts highly readable, concise chapters with hundreds of useful photos, diagrams, algorithms, and clinical pearls. Clear, logical, organ-system approach allows you to focus on the development, function, and treatment of a wide range of disease entities. Includes new content on the expanding use of ultrasound at the bedside and the increase in nursing responsibilities in the PICU. Eighteen new chapters cover topics such as delirium, metabolism, endocrinology, nutrition, nursing, and much more. Features expanded and updated information on critical communication, professionalism, long-term outcomes, palliative care, ultrasonography, PCCM in resource-limited settings, ventilator-induced lung injury, non-invasive ventilation, updated CNS pathophysiology, the ‘Erythron’, and immunity and infection. |
| epoprostenol therapy side effects: Textbook of Clinical Hemodynamics Michael Ragosta, 2008-01-01 Here's a source of guidance on the analysis of the hemodynamic waveforms generated in the cardiac catheterization lab. It progresses from a review of basic monitoring principles and normal waveforms through an assessment of the waveform data associated with the full range of individual coronary diseases, providing the assistance needed to accurately interpret any findings encountered in practice. Its extremely clinically oriented approach makes it an ideal hands-on tool for any clinician involved in diagnosing cardiac problems using interventional cardiology. |
Fact Sheet - National Scleroderma Foundation
Nov 27, 2021 · Patients with moderate or severe PH usually notice shortness of breath (dyspnea), especially with exercise. Patients may also notice unusual chest pains and symptoms of right …
PATIENT & CAREGIVER EDUCATION Epoprostenol - Memorial …
WARNING/CAUTION: Even though it may be rare, some people may have very bad and sometimes deadly side effects when taking a drug. Tell your doctor or get medical help right …
Transition from Intravenous Epoprostenol to Treprostinil Due …
Reviewing the side effects associated with epoprostenol and treprostinil is essential for improving the long-term treatment strategies for PAH.
Nursing Services Guideline General - The University of Toledo
These effects include, but are not limited to: hypotension, pulmonary edema, rebound pulmonary hypertension, flushing, chest pain, and nausea/vomiting. During transitions of care, patients …
Management of prostacyclin side effects in adult patients with ...
Apr 11, 2017 · Therapies that target the prostacyclin pathway are considered effective, yet are complex to dose and may cause dose-limiting side effects for patients with pulmonary arterial …
Inhaled Epoprostenol - mwhcpulmonaryservices.org
• Inhalation of epoprostenol aerosol is an alternative route of delivery that may improve ventilation–perfusion matching in secondary PH. • Aerosolized epoprostenol should NOT be …
Hemodynamic Effects of Epoprostenol in Patients With …
Results: Eight of nine patients demonstrated a reduction of > 20% in PVR, suggesting that vasoreactivity is common despite the presence of significant ILD. A single patient had no …
Metered Dose Inhaler Treatment Via Ventilator - UTMB Health
Epoprostenol is FDA approved for the treatment of primary pulmonary hypertension by intravenous infusion, but its use is limited by adverse effects including systemic hypotension …
Epoprostenol as an anticoagulation method in Pediatric CRRT: …
Epoprostenol is associated with extended filter life and a similar side effect profile. Our findings align with these results. However, given the recent adoption and limited use of Epoprostenol in …
Marked Hemodynamic Improvements by High-Dose …
Compared with the baseline state, high-dose epoprostenol therapy reduced mPAP by 30% and PVR by 68%. Conclusions: The present study suggests high-dose epoprostenol therapy is a …
PATIENT & CAREGIVER EDUCATION Epoprostenol - Memorial …
WARNING/CAUTION: Even though it may be rare, some people may have very bad and sometimes deadly side effects when taking a drug. Tell your doctor or get medical help right …
WHAT IS EPOPROSTENOL - phassociation.org
Epoprostenol is an intravenous medication approved for the treatment of pulmonary arterial hypertension (PAH) in World Health Organization (WHO) Group 1 patients. Epoprostenol is a …
Acute effects of nebulised epoprostenol in pulmonary …
Epoprostenol is a potent pulmonary vasodilator and its efficacy has been demonstrated when delivered by the intravenous and aerosolized routes. We report the haemodynamic and …
EFFECTS OF CONTINUOUS INTRAVENOUS EPOPROSTENOL …
Our results suggest that chronic infusion of epoprostenol can improve functional status and survival of Taiwanese patients with advanced PPH disease.
Epoprostenol for Treatment of Pulmonary Hypertension in …
Doses of epoprostenol ranged from 4 to 46 ng/kg/min, and the longest duration of therapy has been 2.5 years. Side effects from epoprostenol have not differed from those seen in patients …
Epoprostenol (Flolan®, Veletri®) - Pulmonary Hypertension …
Epoprostenol is a potent medication used to treat pulmonary arterial hypertension, a type of high blood pressure in the lungs that affects heart function. Epoprostenol works by causing the …
PATIENT & CAREGIVER EDUCATION Epoprostenol - Memorial …
WARNING/CAUTION: Even though it may be rare, some people may have very bad and sometimes deadly side effects when taking a drug. Tell your child’s doctor or get medical help …
Transitioning From IV Epoprostenol to Subcutaneous …
IV epoprostenol therapy may be limited by serious complications related to the need for an implanted central venous catheter, and its chemical instability and short half-life.
Impact of switching from epoprostenol to IV treprostinil on …
Although all patients reported fewer prostacyclin-related side effects using treprostinil versus epoprostenol and all chose to remain on treprostinil after study completion, formal …
WHAT IS EPOPROSTENOL - Pulmonary Hypertension …
what are the main side effects with epoprostenol? The side effects of epoprostenol are similar to those seen with all prostacyclin agents and include:
Fact Sheet - National Scleroderma Foundation
Nov 27, 2021 · Patients with moderate or severe PH usually notice shortness of breath (dyspnea), especially with exercise. Patients may also notice unusual chest pains and symptoms of right …
PATIENT & CAREGIVER EDUCATION Epoprostenol
WARNING/CAUTION: Even though it may be rare, some people may have very bad and sometimes deadly side effects when taking a drug. Tell your doctor or get medical help right …
Transition from Intravenous Epoprostenol to Treprostinil Due …
Reviewing the side effects associated with epoprostenol and treprostinil is essential for improving the long-term treatment strategies for PAH.
Nursing Services Guideline General - The University of Toledo
These effects include, but are not limited to: hypotension, pulmonary edema, rebound pulmonary hypertension, flushing, chest pain, and nausea/vomiting. During transitions of care, patients …
Management of prostacyclin side effects in adult patients …
Apr 11, 2017 · Therapies that target the prostacyclin pathway are considered effective, yet are complex to dose and may cause dose-limiting side effects for patients with pulmonary arterial …
Inhaled Epoprostenol - mwhcpulmonaryservices.org
• Inhalation of epoprostenol aerosol is an alternative route of delivery that may improve ventilation–perfusion matching in secondary PH. • Aerosolized epoprostenol should NOT be …
Hemodynamic Effects of Epoprostenol in Patients With …
Results: Eight of nine patients demonstrated a reduction of > 20% in PVR, suggesting that vasoreactivity is common despite the presence of significant ILD. A single patient had no …
Metered Dose Inhaler Treatment Via Ventilator - UTMB Health
Epoprostenol is FDA approved for the treatment of primary pulmonary hypertension by intravenous infusion, but its use is limited by adverse effects including systemic hypotension …
Epoprostenol as an anticoagulation method in Pediatric …
Epoprostenol is associated with extended filter life and a similar side effect profile. Our findings align with these results. However, given the recent adoption and limited use of Epoprostenol in …
Marked Hemodynamic Improvements by High-Dose …
Compared with the baseline state, high-dose epoprostenol therapy reduced mPAP by 30% and PVR by 68%. Conclusions: The present study suggests high-dose epoprostenol therapy is a …
PATIENT & CAREGIVER EDUCATION Epoprostenol
WARNING/CAUTION: Even though it may be rare, some people may have very bad and sometimes deadly side effects when taking a drug. Tell your doctor or get medical help right …
WHAT IS EPOPROSTENOL - phassociation.org
Epoprostenol is an intravenous medication approved for the treatment of pulmonary arterial hypertension (PAH) in World Health Organization (WHO) Group 1 patients. Epoprostenol is a …
Acute effects of nebulised epoprostenol in pulmonary …
Epoprostenol is a potent pulmonary vasodilator and its efficacy has been demonstrated when delivered by the intravenous and aerosolized routes. We report the haemodynamic and …
EFFECTS OF CONTINUOUS INTRAVENOUS EPOPROSTENOL …
Our results suggest that chronic infusion of epoprostenol can improve functional status and survival of Taiwanese patients with advanced PPH disease.
Epoprostenol for Treatment of Pulmonary Hypertension in …
Doses of epoprostenol ranged from 4 to 46 ng/kg/min, and the longest duration of therapy has been 2.5 years. Side effects from epoprostenol have not differed from those seen in patients …
Epoprostenol (Flolan®, Veletri®) - Pulmonary Hypertension …
Epoprostenol is a potent medication used to treat pulmonary arterial hypertension, a type of high blood pressure in the lungs that affects heart function. Epoprostenol works by causing the …
PATIENT & CAREGIVER EDUCATION Epoprostenol
WARNING/CAUTION: Even though it may be rare, some people may have very bad and sometimes deadly side effects when taking a drug. Tell your child’s doctor or get medical help …
Transitioning From IV Epoprostenol to Subcutaneous …
IV epoprostenol therapy may be limited by serious complications related to the need for an implanted central venous catheter, and its chemical instability and short half-life.
Impact of switching from epoprostenol to IV treprostinil on …
Although all patients reported fewer prostacyclin-related side effects using treprostinil versus epoprostenol and all chose to remain on treprostinil after study completion, formal …
